101 related articles for article (PubMed ID: 12859998)
1. Restimulation of tumour-specific immunity in a patient with AML following injection with B7-1 positive autologous blasts.
Hicks C; Cheung C; Lindeman R
Leuk Res; 2003 Nov; 27(11):1051-61. PubMed ID: 12859998
[TBL] [Abstract][Full Text] [Related]
2. In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy.
Orleans-Lindsay JK; Deru A; Craig JI; Prentice HG; Lowdell MW
Clin Exp Immunol; 2003 Sep; 133(3):467-75. PubMed ID: 12930376
[TBL] [Abstract][Full Text] [Related]
3. CD80 (B7-1) expression on human acute myeloid leukaemic cells cultured with GM-CSF, IL-3 and IL-6.
Hicks C; Keoshkerian E; Gaudry L; Lindeman R
Cancer Immunol Immunother; 2001 Jun; 50(4):173-80. PubMed ID: 11459169
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells.
Cardoso AA; Seamon MJ; Afonso HM; Ghia P; Boussiotis VA; Freeman GJ; Gribben JG; Sallan SE; Nadler LM
Blood; 1997 Jul; 90(2):549-61. PubMed ID: 9226154
[TBL] [Abstract][Full Text] [Related]
6. Core-binding factor-beta positive acute myeloid leukaemia cells induce T-cell responses.
Banat GA; Ihlow K; Usluoglu N; Hoppmann S; Hoeck M; Pralle H
Br J Haematol; 2003 Dec; 123(5):819-29. PubMed ID: 14632772
[TBL] [Abstract][Full Text] [Related]
7. Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells.
Notter M; Willinger T; Erben U; Thiel E
Blood; 2001 May; 97(10):3138-45. PubMed ID: 11342441
[TBL] [Abstract][Full Text] [Related]
8. Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission.
Whiteway A; Corbett T; Anderson R; Macdonald I; Prentice HG
Br J Haematol; 2003 Feb; 120(3):442-51. PubMed ID: 12580958
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells fused with core binding factor-beta positive acute myeloid leukaemia blast cells induce activation of cytotoxic lymphocytes.
Banat GA; Usluoglu N; Hoeck M; Ihlow K; Hoppmann S; Pralle H
Br J Haematol; 2004 Aug; 126(4):593-601. PubMed ID: 15287954
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T cells activated during the course of murine acute myelogenous leukemia elicit therapeutic responses to late B7 vaccines after cytoreductive treatment.
Dunussi-Joannopoulos K; Krenger W; Weinstein HJ; Ferrara JL; Croop JM
Blood; 1997 Apr; 89(8):2915-24. PubMed ID: 9108412
[TBL] [Abstract][Full Text] [Related]
11. gamma-ray irradiation induces B7.1 expression in myeloid leukaemic cells.
Vereecque R; Buffenoir G; Gonzalez R; Cambier N; Hetuin D; Bauters F; Fenaux P; Quesnel B
Br J Haematol; 2000 Mar; 108(4):825-31. PubMed ID: 10792289
[TBL] [Abstract][Full Text] [Related]
12. Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia.
Westers TM; Stam AG; Scheper RJ; Regelink JC; Nieuwint AW; Schuurhuis GJ; van de Loosdrecht AA; Ossenkoppele GJ
Cancer Immunol Immunother; 2003 Jan; 52(1):17-27. PubMed ID: 12536236
[TBL] [Abstract][Full Text] [Related]
13. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
[TBL] [Abstract][Full Text] [Related]
14. IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
Chan L; Hardwick N; Darling D; Galea-Lauri J; Gäken J; Devereux S; Kemeny M; Mufti G; Farzaneh F
Mol Ther; 2005 Jan; 11(1):120-31. PubMed ID: 15585413
[TBL] [Abstract][Full Text] [Related]
15. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Hoskin DW
J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production.
Soos JM; Ashley TA; Morrow J; Patarroyo JC; Szente BE; Zamvil SS
Int Immunol; 1999 Jul; 11(7):1169-79. PubMed ID: 10383950
[TBL] [Abstract][Full Text] [Related]
18. Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy.
Seko Y; Takahashi N; Ishiyama S; Nishikawa T; Kasajima T; Hiroe M; Suzuki S; Ishiwata S; Kawai S; Azuma M; Yagita H; Okumura K; Yazaki Y
Circulation; 1998 Feb; 97(7):637-9. PubMed ID: 9495297
[TBL] [Abstract][Full Text] [Related]
19. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
[TBL] [Abstract][Full Text] [Related]
20. Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1.
Hirst WJ; Buggins A; Darling D; Gäken J; Farzaneh F; Mufti GJ
Gene Ther; 1997 Jul; 4(7):691-9. PubMed ID: 9282170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
